Virginie Adam
@virginieadam.bsky.social
🇺🇸 🇧🇪 PhD in oncology & virology 🧬, breast cancer clinical research at Breast International Group 🎀, mama of a 5yo 👦 & a 2yo 🧒, passionate about helping patients around the 🌍
Reposted by Virginie Adam
📢 Just published! BIG’s Patient Partnership shows how people with lived experience can shape global breast cancer research. 🎀🌍 A model for research with patients, not just for them. BIG thank you to our patient partners! 💞 doi.org/10.1016/j.br...
November 21, 2025 at 4:16 PM
📢 Just published! BIG’s Patient Partnership shows how people with lived experience can shape global breast cancer research. 🎀🌍 A model for research with patients, not just for them. BIG thank you to our patient partners! 💞 doi.org/10.1016/j.br...
Reposted by Virginie Adam
#APHINITY: LBA1 - The final overall survival analysis with a median follow-up 11.3 years will be presented at #ESMOBreast25 by @LoiblSibylle. Join us tomorrow at 15:00 in the Proffered Paper Session, room 14. @JulesBordet @IEOufficiale FSS
May 14, 2025 at 8:10 AM
#APHINITY: LBA1 - The final overall survival analysis with a median follow-up 11.3 years will be presented at #ESMOBreast25 by @LoiblSibylle. Join us tomorrow at 15:00 in the Proffered Paper Session, room 14. @JulesBordet @IEOufficiale FSS
Reposted by Virginie Adam
The growing impact of climate change 🔥🌪️⛈️🌊☀️ on how we conduct trials & the multiple opportunities for ♻️sustainability in our community.
Grateful to 🏴🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴 co authors & @bigxresearch.bsky.social members who completed the survey
Grateful to 🏴🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴 co authors & @bigxresearch.bsky.social members who completed the survey
April 22, 2025 at 2:18 PM
The growing impact of climate change 🔥🌪️⛈️🌊☀️ on how we conduct trials & the multiple opportunities for ♻️sustainability in our community.
Grateful to 🏴🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴 co authors & @bigxresearch.bsky.social members who completed the survey
Grateful to 🏴🇬🇧🇧🇪🇮🇪🇸🇪🇬🇷🇧🇷🏴 co authors & @bigxresearch.bsky.social members who completed the survey
Reposted by Virginie Adam
The #AURORA Data Analysis Committee is in Florence for a “datathon”! Over the next 2 days, PIs, bioinformaticians, clinicians, and BIG HQ are working together on analyses to advance a new AURORA manuscript. @aftimosp.bsky.social
@elisaagostinetto.bsky.social
@elisaagostinetto.bsky.social
April 10, 2025 at 11:13 AM
The #AURORA Data Analysis Committee is in Florence for a “datathon”! Over the next 2 days, PIs, bioinformaticians, clinicians, and BIG HQ are working together on analyses to advance a new AURORA manuscript. @aftimosp.bsky.social
@elisaagostinetto.bsky.social
@elisaagostinetto.bsky.social
Congratulations Siobhan! 🌟Wonderful to see recognition for all your work on the patient-led survey of patients with metastatic #breastcancer in Ireland!!
Standing ovation for the wonderful patient advocate Siobhan Gaynor at Irish Cancer Society Awards 🥇her commitment will improve care of all ☘️ patients with advanced cancer . 🙏to patients for their generous support.
✍️ from study 👇 #OncSky
www.thebreastonline.com/article/S096...
✍️ from study 👇 #OncSky
www.thebreastonline.com/article/S096...
February 21, 2025 at 10:27 AM
Congratulations Siobhan! 🌟Wonderful to see recognition for all your work on the patient-led survey of patients with metastatic #breastcancer in Ireland!!
Reposted by Virginie Adam
🚨 The final analysis of the phase 3 #ALEXANDRA/IMpassion030 study on adding atezolizumab to post-op chemo for high-risk early-stage #TNBC is out in @jama.com, contributing to a greater understanding of immunotherapy in #breastcancer👉 jamanetwork.com/journals/jam...
@mignatiadis.bsky.social
@mignatiadis.bsky.social
January 30, 2025 at 4:20 PM
🚨 The final analysis of the phase 3 #ALEXANDRA/IMpassion030 study on adding atezolizumab to post-op chemo for high-risk early-stage #TNBC is out in @jama.com, contributing to a greater understanding of immunotherapy in #breastcancer👉 jamanetwork.com/journals/jam...
@mignatiadis.bsky.social
@mignatiadis.bsky.social